Carr Brendan M, Romeiser Jamie, Ruan Joyce, Gupta Sandeep, Seifert Frank C, Zhu Wei, Shroyer A Laurie
Department of Surgery, Stony Brook Medicine, Stony Brook University, Stony Brook, New York.
Department of Applied Mathematics and Statistics, College of Engineering and Applied Sciences, Stony Brook University, Stony Brook, New York.
J Card Surg. 2016 Jan;31(1):23-30. doi: 10.1111/jocs.12665. Epub 2015 Nov 5.
BACKGROUND/AIM: Clinical risk models are commonly used to predict short-term coronary artery bypass grafting (CABG) mortality but are less commonly used to predict long-term mortality. The added value of long-term mortality clinical risk models over traditional actuarial models has not been evaluated. To address this, the predictive performance of a long-term clinical risk model was compared with that of an actuarial model to identify the clinical variable(s) most responsible for any differences observed.
Long-term mortality for 1028 CABG patients was estimated using the Hannan New York State clinical risk model and an actuarial model (based on age, gender, and race/ethnicity). Vital status was assessed using the Social Security Death Index. Observed/expected (O/E) ratios were calculated, and the models' predictive performances were compared using a nested c-index approach. Linear regression analyses identified the subgroup of risk factors driving the differences observed.
Mortality rates were 3%, 9%, and 17% at one-, three-, and five years, respectively (median follow-up: five years). The clinical risk model provided more accurate predictions. Greater divergence between model estimates occurred with increasing long-term mortality risk, with baseline renal dysfunction identified as a particularly important driver of these differences.
Long-term mortality clinical risk models provide enhanced predictive power compared to actuarial models. Using the Hannan risk model, a patient's long-term mortality risk can be accurately assessed and subgroups of higher-risk patients can be identified for enhanced follow-up care. More research appears warranted to refine long-term CABG clinical risk models.
背景/目的:临床风险模型常用于预测冠状动脉旁路移植术(CABG)的短期死亡率,但较少用于预测长期死亡率。长期死亡率临床风险模型相对于传统精算模型的附加价值尚未得到评估。为解决这一问题,将长期临床风险模型的预测性能与精算模型进行比较,以确定导致观察到的差异的最主要临床变量。
使用汉南纽约州临床风险模型和精算模型(基于年龄、性别和种族/民族)估计1028例CABG患者的长期死亡率。使用社会保障死亡指数评估生存状态。计算观察/预期(O/E)比率,并使用嵌套c指数方法比较模型的预测性能。线性回归分析确定了导致观察到的差异的风险因素亚组。
1年、3年和5年时的死亡率分别为3%、9%和17%(中位随访时间:5年)。临床风险模型提供了更准确的预测。随着长期死亡风险增加,模型估计值之间的差异更大,基线肾功能不全被确定为这些差异的一个特别重要的驱动因素。
与精算模型相比,长期死亡率临床风险模型具有更强的预测能力。使用汉南风险模型,可以准确评估患者的长期死亡风险,并识别出高风险患者亚组,以便加强后续护理。似乎有必要进行更多研究来完善长期CABG临床风险模型。